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Background: In liver surgery, appropriate preoperative evaluation and preparation of the patient is of cardinal
importance. The up-to-date, preoperative prediction of residual liver function has thus far been limited. As post-
hepatectomy liver failure is a major cause of mortality, a new and simple bedside test (LiMAx) has been developed
to predict postoperative liver function in conjunction with preoperative volumetric analysis of the liver.
Case presentation: A 45-year-old patient presented with a cecal carcinoma and a large synchronous liver
metastasis for major liver surgery. Liver function was determined by the LiMAx-test for the enzymatic capacity of
cytochrome P450 1A2, which is ubiquitously and solely active in the liver. A solution of 2 mg/kg body weight
13C-labeled methacetin was injected as a bolus into an intravenous catheter and, thereafter, was metabolized into
acetaminophen and 13CO2 and pulmonarily exhaled. The analysis of the 13CO2/12CO2 ratio was performed using
online breath sampling over a period of maximally 60 minutes. Based on this test, a value of more than 315 μg/kg/h
represents normal liver function. A laparoscopic right hemihepatectomy was planned during virtual resection with a
residual liver volume of 48% and a preoperative anticipated residual LiMAx of 301 μg/kg/h. After successful resection,
the initial postoperative LiMAx value was 316 μg/kg/h, indicating good liver function and a correct prediction of the
outcome.
Conclusion: In the presented patient, residual liver function could be accurately predicted preoperatively using a
combination of the new LiMax test with CT-volumetry. This test might significantly improve preoperative evaluation
and postoperative outcomes in liver surgery.
Keywords: Liver function, Liver volumetry, Liver resection, Liver function measurement, LiMAxBackground
Improvements in surgical techniques, anesthetic proto-
cols, and perioperative care have decreased morbidity
and mortality and have contributed to an increase in
extended liver resections. This more aggressive approach
inevitably leads to smaller remnant livers with a substan-
tially elevated risk of post-resectional liver failure (PLF)
[1-3]. It was demonstrated that 80% of deaths caused by
PLF occur after resecting more than 50% of the liver
volume [4-6], and the PLF incidence increases with the
number of resected segments [5]. Therefore, accurate
preoperative volumetric calculation of total and partial
liver volumes based on preoperative imaging and* Correspondence: Sascha.mueller@kssg.ch
1Department of Surgery, Kantonsspital St.Gallen, St.Gallen, Switzerland
3Rorschacherstrasse 95, 9007 St.Gallen, Switzerland
Full list of author information is available at the end of the article
© 2013 Müller et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orresection planning is crucial in the assessment of hepatic
functional reserve and resectability, especially in cases of
major liver resection and patients with underlying par-
enchymal disease [7]. Liver steatosis and steatohepatitis,
for example, are associated with an increased risk of PLF
after partial liver resection, especially after neoadjuvant
chemotherapy, or in living donor liver transplantation
[8]. Traditional methods estimating the hepatic func-
tional reserve, such as liver enzyme tests and Child-
Pugh classification, have clinical and practical limitations
[9]. The major disadvantage of most quantitative liver
function tests, such as the indocyanine green clearance
test and the galactose elimination capacity, is that they
are influenced by several factors such as hepatic blood
flow and hyperbilirubinemia [10]. Moreover, no reliable
cutoffs and guidelines could be defined. Consequently, clin-
ical decisions mainly rely on the surgeon’s experience [1].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Three-dimensional computation from a preoperative
CT scan of the patient with a large liver metastasis (superior
view). The portal vein is pink and green, the hepatic veins are blue,
and the tumor is yellow.
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reliably measure total liver function or predict the postoper-
ative outcome. Here, we present the LiMAx-test, which has
been developed at the Department of General, Visceral and
Transplantation Surgery at the Charité in Berlin [11]. The
test has been successfully evaluated in many patients
undergoing liver surgery and liver transplantation since
2003 [11,12]. This test is now used in all patients with
planned liver resection in our surgical department and in
several other European centers.
The new LiMAx-test
This breath test is based on the hepatocyte-specific
metabolism of the cytochrome P450 1A2 enzyme, which
is active throughout the liver. After 3 hours of fasting,
patients are placed in a resting horizontal position. The
activity of the enzyme is measured by i.v. bolus injection of
non-radioactive 13C-methacetin (2 mg/kg body weight).
Ten minutes prior to the injection with 13C-methacetin, the
baseline 13CO2/
12CO2 ratio is recorded.
13C-methacetin
(Euriso-top, Saint-Aubin, Cedex, France) is metabolized
into acetaminophen and 13CO2, which is pulmonarily
exhaled. The exhaled air is collected using a face mask
(Humedics GmbH, Berlin Germany), and the 13CO2/
12CO2
ratio in the air is determined using a modified nondispersive
isotope-selective infrared spectroscopy (FANci2-db16, Fischer
Analysen Instumente, Leipzig, Germany, Humedics GmbH,
Berlin, Germany) [11,13]. Based on the 13CO2/
12CO2 ratio
and the body weight, the cytochrome P450 1A2 activity
is determined using the so-called LiMAx value with the
unit μg/kg/h (μg methacetin/kg body weight/hour). The
analysis of the 13CO2/12CO2 ratio is performed over a
period of 20 to 60 minutes. For normal liver function, a
LiMAx value over 315 μg/kg/h is required. In healthy
volunteers, the normal range of LiMAx was found to be
425 ± 67 μg/kg/h (range 311-575 μg/kg/h). Further-
more, the correlation between repeated measurements
was found to be 0.82 [11].
Case report
A 45-year-old patient in good general health presented
with a cecal carcinoma and a large synchronous liver
metastasis. After neo-adjuvant chemotherapeutic treat-
ment with 5-FU, Irinotecan and Oxaliplatin, a “liver first”
approach was decided by the tumor board. The preopera-
tive LiMAx value was 622 μg/kg/h, functional liver
volume was 1736 mL, and tumor volume was 351 mL. A
laparoscopic left hemihepatectomy was planned during
virtual resection with a functional resection of 895 mL,
resulting in a residual liver volume of 841 mL (48%) and a
pre-operatively anticipated residual LiMAx of 301 μg/kg/h
(Figure 1). The laparoscopic left hemihepatectomy was
performed under general anesthesia in the supine position
using 5 ports according to the technique described byPearce et al. [14]. Briefly after applying a nylon tape around
the portal triad for the Pringle maneuver, the liver was
completely mobilized. The resection plane was defined by
intraoperative ultrasound. After vascular control, the dis-
section was performed by harmonic scalpel (Harmonic
ACE; Ethicon Endo-Surgery, Cincinnati, OH, USA) and
Cavitron Ultrasonic Surgical Aspirator (Valleylab, Boulder,
CO, USA) under intermittent Pringle maneuver. After
completion of adequate hemostasis, the specimen was re-
moved in an impermeable bag (Endocatch; Ethicon Endo-
Surgery) introduced through a 15-mm suprapubic port
subsequently extended through a Pfannenstiel incision.
The operation time was 5.5 hours, and the intraoperative
blood loss was 300 mL.
After successful resection, the initial postoperative
LiMAx value on postoperative day one was 316 μg/kg/h,
indicating good liver function and correct prediction of
the outcome. After an uneventful postoperative course,
the patient was discharged on postoperative day six.
Eight days later, an uneventful laparoscopic right
hemicolectomy was performed to remove the primary
tumor.Discussion
As impressively demonstrated by the presented case, the
LiMAx-test in combination with a CT-based liver
volumetry can reliably predict the postoperative liver
function. Therefore, we adopted these preoperative tests
as a standard procedure for every patient undergoing
liver resection at our institution.
In 2010, Stockmann et al. published the LiMAx algo-
rithm, which is an easily applicable clinical decision tree
for preoperative resection planning [15]. This allows
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major complications or even liver failure-related death.
Normal liver function (LiMAx >315 μg/kg/h) allows the
resection of up to four liver segments without further
consideration. By contrast, patients with strongly im-
paired liver function (LiMAx <140 μg/kg/h, indicating
significant hepatic injury) are not eligible for surgery as
they are prone to developing postoperative liver failure
even after minor liver resection. Patients with limited
hepatic impairment and a preoperative LiMAx-value be-
tween 140–315 μg/kg/h are the most challenging ones.
In these patients, precise liver volumetry is mandatory
for a planned major liver resection (>four liver seg-
ments). Resections with an expected residual LiMAx
value less than 80 μg/kg/h should be avoided because
they are associated with a high mortality of up to 40%.
Planned resections with a predicted residual LiMAx
value between 80–100 μg/kg/h are considered critical
(10.5% postoperative mortality), and thus alternative
therapies or additional preoperative procedures should be
considered (i.e., portal vein embolization, neo-adjuvant
chemotherapy to downstage tumors). Liver resections
with expected residual LiMAx values of >100 μg/kg/h can
safely be performed.
The LiMAx test can clearly help to avoid post-
resectional liver failure. Thus, one could expect a rele-
vant impact on health care costs. Recently, Lock et al.
published a study examining 45 patients after major liver
resection [16]. Eight patients developed postoperative
liver failure, seven of these died in the postoperative
course. Patients developing post-resectional liver failure
generated higher costs than patients without post-
resectional liver failure (82,199 € [95%CI: 42,812 –
21,586 €] vs. 25,980 € [95%CI: 9,559 – 42,401 €]; p = 0.013)
[14]. The proportion of intensive-care unit cost relative to
total costs increased from 30% to more than 50%, and the
cost for blood tests and products from the blood bank
increased more than eightfold from 819 € [95%CI: 0 –
1,837 €] to 6,953 € [95%CI: 4,512 – 9,395 €]; p ≤ 0.001).
In covariate analysis, overall costs related to post-
resectional liver failure were 56,219 € [95%CI: 12,327 –
100,066 €]. Routinely applying the LiMAx test, we can
achieve an optimized and individualized treatment for
patients scheduled for liver resections. This ultimately
leads to economic savings by significantly decreasing
morbidity and mortality and the overall length of hos-
pital stay.
Conclusion
In the presented patient, residual liver function could be
accurately predicted preoperatively by the combination
of the new LiMax test with CT-volumetry. Considering
the existing literature, the LiMAx test significantlyimproves preoperative evaluation and postoperative out-
comes in liver surgery.
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